Venture Capital

Ultragenyx's stock plummets after its Osteogenesis Imperfecta drug fails to reduce fractures, a major blow for patients and a test of the firm's pipeline.

A new VR experience from Braindance uses a radical rendering method to make virtual worlds feel less like a game and more like a place you can truly occupy.

As its cash runway shortens, Longeveron's novel stem cell therapy gets a major boost with selection for a prestigious Alzheimer's health moonshot.

Facing soaring demand, AI robotics firm TechForce is seeking a global manufacturing partner, signaling a major shift from pilot programs to mass production.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.

A Korean pet food brand's surprise win over tech giants at a top pitch event signals a major shift in what venture capitalists value. Here's why.

The investment firm sheds its medical focus, adopting a new name and a broader mandate to chase cross-sector opportunities in the booming AI market.

With its 'Results Your Way' plan, the fitness giant is rolling out personalized coaching, recovery zones, and Pilates to compete in a changing market.

Sofie Biosciences begins late-stage trials for a novel PET scan targeting aggressive gastrointestinal cancers, a breakthrough that could redefine detection.

With promising new drugs for obesity and liver disease, clinical-stage MetaVia steps into the spotlight at a key industry conference, facing giants and high hopes.

With a promising schizophrenia drug stalled by FDA requirements and finances tight, Reviva Pharmaceuticals' upcoming presentation is more than just a talk.

Semiconductor metrology leader Nova adds seasoned investor Rami Hadar to its board, signaling a strategic push to accelerate growth and innovation.

Core AI divests its cash-burning Siyata Mobile hardware unit just months after merging, betting its future entirely on AI-powered gaming and content.

Metallis Resources adds a renowned gold-finder to its team to unlock a historic, high-grade Idaho property rich in gold, silver, and critical minerals.

A Korean AI startup raised $854K for a gesture-control ring, betting its enterprise-grade tech can unlock the future of post-touch computing.

After resolving a key manufacturing issue, Unicycive has resubmitted its kidney drug NDA, offering new hope for dialysis patients with a lower pill burden.

Gogo has launched its anticipated 5G network for business jets, promising a new era of speed. But can its regional advantage hold against global satellite rivals?

Traini's new generative AI collar claims to translate dog emotions into human language. But does the science back up this multi-million dollar bet?

REE Automotive and BorgWarner's Cascadia Motion partner to create a revolutionary 'off-the-shelf' electric drive unit, accelerating the EV transition.

Greenwich LifeSciences execs extend their stock lock-up to 6 years, signaling massive confidence in their breast cancer drug showing an 80% recurrence drop.